Hypothalamic Apelin/Reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes

Antioxidants and Redox Signaling

Volumn 20, Issue 4, 2014, Pages 557-573

  Drougard, Anne ^a,b   Duparc, Thibaut ^a,b   Brenachot, Xavier ^a,b,c   Carneiro, Lionel ^c   Gouazé, Alexandra ^c   Fournel, Audren ^a,b   Geurts, Lucie ^d   Cadoudal, Thomas ^a,b   Prats, Anne Catherine ^e   Pénicaud, Luc ^c   Vieau, Didier ^f   Lesage, Jean ^f   Leloup, Corinne ^c   Benani, Alexandre ^c   Cani, Patrice D ^d   Valet, Philippe ^a,b   Knauf, Claude ^a,b  

^a INSERM   (France)

^b Université de Toulouse   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; GLUCOSE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MEGADOSE; GENE OVEREXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HYPERGLYCEMIA; HYPOTHALAMUS; LIPID DIET; LIVER FUNCTION; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCONEOGENESIS; GLUCOSE; GLYCOGENOLYSIS; HYPOTHALAMUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84892932862     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5182     Document Type: Article

References (58)

1. Agius L. New hepatic targets for glycaemic control in diabetes. Best Pract Res Clin Endocrinol Metab 21: 587-605, 2007.
2. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW, 3rd, Kang L, Rabinovitch PS, Szeto HH, Houmard JA, Cortright RN, Wasserman DH, and Neufer PD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119: 573-581, 2009.
3. Bao L, Avshalumov MV, Patel JC, Lee CR, Miller EW, Chang CJ, and Rice ME. Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling. J Neurosci 29: 9002-9010, 2009.
4. Bernard H, Garmy-Susini B, Ainaoui N, Van Den Berghe L, Peurichard A, Javerzat S, Bikfalvi A, Lane DP, Bourdon JC, and Prats AC. The p53 isoform, Delta133p53alpha, stimulates angiogenesis and tumour progression. Oncogene 32: 2150-2160, 2012.
5. Burcelin R, Knauf C, and Cani PD. Pancreatic alpha-cell dysfunction in diabetes. Diabetes Metab 34 Suppl 2: S49-S55, 2008.
6. Cai D. Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab 24: 40-47, 2013.
7. Castan-Laurell I, Dray C, Knauf C, Kunduzova O, and Valet P. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol Metab 23: 234-241, 2012.
8. Colombani AL, Carneiro L, Benani A, Galinier A, Jaillard T, Duparc T, Offer G, Lorsignol A, Magnan C, Casteilla L, Penicaud L, and Leloup C. Enhanced hypothalamic glucose sensing in obesity: alteration of redox signaling. Diabetes 58: 2189-2197, 2009.
9. Consoli A. Role of liver in pathophysiology of NIDDM. Diabetes Care 15: 430-441, 1992.
10. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, Cani PD, Attane C, Guigne C, Carpene C, Burcelin R, Castan-Laurell I, and Valet P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437-445, 2008.
11. Duparc T, Colom A, Cani PD, Massaly N, Rastrelli S, Drougard A, Le Gonidec S, Mouledous L, Frances B, Leclercq I, Llorens-Cortes C, Pospisilik JA, Delzenne NM, Valet P, Castan-Laurell I, and Knauf C. Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice. Antioxid Redox Signal 15: 1477-1496, 2011.
12. Duparc T, Naslain D, Colom A, Muccioli GG, Massaly N, Delzenne NM, Valet P, Cani PD, and Knauf C. Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus. Antioxid Redox Signal 14: 415-423, 2011.
13. Erraji-Benchekroun L, Couton D, Postic C, Borde I, Gaston J, Guillet JG, and Andre C. Overexpression of beta2-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes. Am J Physiol Endocrinol Metab 288: E715-E722, 2005.
14. Everard A, Geurts L, Van Roye M, Delzenne NM, and Cani PD. Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PLoS One 7: e33858, 2012.
15. Fisher-Wellman KH and Neufer PD. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol Metab 23: 142-153, 2012.
16. Foussal C, Lairez O, Calise D, Pathak A, Guilbeau-Frugier C, Valet P, Parini A, and Kunduzova O. Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett 584: 2363-2370, 2010.
17. Geurts L, Everard A, le Ruyet P, Delzenne NM, and Cani PD. Ripened dairy products differentially affect hepatic lipid content and adipose tissue oxidative stress markers in obese and type 2 diabetic mice. J Agric Food Chem 60: 2063-2068, 2012.
18. Greenfield JR and Campbell LV. Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: targets for therapy? Curr Pharm Des 14: 1815-1820, 2008.
19. Jaillard T, Roger M, Galinier A, Guillou P, Benani A, Leloup C, Casteilla L, Penicaud L, and Lorsignol A. Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: an NADPH oxidase-dependent mechanism. Diabetes 58: 1544-1549, 2009.
20. John GW, Doxey JC, Walter DS, and Reid JL. The role of alpha-and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat. Br J Pharmacol 100: 699-704, 1990.
21. Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Gremeaux T, Drucker DJ, Kahn CR, Girard J, Tanti JF, Delzenne NM, Postic C, and Burcelin R. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 115: 3554-3563, 2005.
22. Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, and O'Dowd BF. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146: 231-236, 2005.
23. Leloup C, Casteilla L, Carriere A, Galinier A, Benani A, Carneiro L, and Penicaud L. Balancing mitochondrial redox signaling: a key point in metabolic regulation. Antioxid Redox Signal 14: 519-530, 2011.
24. Leloup C, Magnan C, Benani A, Bonnet E, Alquier T, Offer G, Carriere A, Periquet A, Fernandez Y, Ktorza A, Casteilla L, and Penicaud L. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes 55: 2084-2090, 2006.
25. Levin BE, Magnan C, Dunn-Meynell A, and Le Foll C. Metabolic sensing and the brain: who, what, where, and how? Endocrinology 152: 2552-2557, 2011.
26. Lv SY, Qin YJ, Wang NB, Yang YJ, and Chen Q. Supraspinal antinociceptive effect of apelin-13 in a mouse visceral pain model. Peptides 37: 165-170, 2012.
27. Masaki T, Yasuda T, and Yoshimatsu H. Apelin-13 microinjection into the paraventricular nucleus increased sympathetic nerve activity innervating brown adipose tissue in rats. Brain Res Bull 87: 540-543, 2012.
28. Miyamoto L, Ebihara K, Kusakabe T, Aotani D, Yamamoto-Kataoka S, Sakai T, Aizawa-Abe M, Yamamoto Y, Fujikura J, Hayashi T, Hosoda K, and Nakao K. Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and alpha1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin. J Biol Chem 287: 40441-40447, 2012.
29. Molendi-Coste O, Grumolato L, Laborie C, Lesage J, Maubert E, Ghzili H, Vaudry H, Anouar Y, Breton C, and Vieau D. Maternal perinatal undernutrition alters neuronal and neuroendocrine differentiation in the rat adrenal medulla at weaning. Endocrinology 147: 3050-3059, 2006.
30. Moore MC, Connolly CC, and Cherrington AD. Autoregulation of hepatic glucose production. Eur J Endocrinol 138: 240-248, 1998.
31. Morgan NG, Blackmore PF, and Exton JH. Age-related changes in the control of hepatic cyclic AMP levels by alpha 1-and beta 2-adrenergic receptors in male rats. J Biol Chem 258: 5103-5109, 1983.
32. Murphy MP, Holmgren A, Larsson NG, Halliwell B, Chang CJ, Kalyanaraman B, Rhee SG, Thornalley PJ, Partridge L, Gems D, Nystrom T, Belousov V, Schumacker PT, and Winterbourn CC. Unraveling the biological roles of reactive oxygen species. Cell Metab 13: 361-366, 2011.
33. Perez-Maceira JJ, Mancebo MJ, and Aldegunde M. Serotonin-induced brain glycogenolysis in rainbow trout (Oncorhynchus mykiss). J Exp Biol 215: 2969-2979, 2012.
34. Pocai A, Morgan K, Buettner C, Gutierrez-Juarez R, Obici S, and Rossetti L. Central leptin acutely reverses dietinduced hepatic insulin resistance. Diabetes 54: 3182-3189, 2005.
35. Pogson CI and Smith SA. The activity of phosphoenolpyruvate carboxykinase in rat tissues. Assay techniques and effects of dietary and hormonal changes. Biochem J 152: 401-408, 1975.
36. Postic C, Dentin R, and Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30: 398-408, 2004.
37. Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani JP, Barzel B, and Head GA. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 55: 862-868, 2010.
38. Prodi E and Obici S. Minireview: the brain as a molecular target for diabetic therapy. Endocrinology 147: 2664-2669, 2006.
39. Purkayastha S, Zhang H, Zhang G, Ahmed Z, Wang Y, and Cai D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc Natl Acad Sci USA 108: 2939-2944, 2011.
40. Rajas F, Bruni N, Montano S, Zitoun C, and Mithieux G. The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats. Gastroenterology 117: 132-139, 1999.
41. Ramnanan CJ, Edgerton DS, Kraft G, and Cherrington AD. Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab 13 Suppl 1: 118-125, 2011.
42. Reaux-Le Goazigo A, Bodineau L, De Mota N, Jeandel L, Chartrel N, Knauf C, Raad C, Valet P, and Llorens-Cortes C. Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic alpha-MSH release. Am J Physiol Endocrinol Metab 301: E955-E966, 2011.
43. Saint-Geniez M, Masri B, Malecaze F, Knibiehler B, and Audigier Y. Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels. Mech Dev 110: 183-186, 2002.
44. Shimazu T. The effect of electric stimulation of hypothalamus on rabbit liver tryptophan pyrrolase. Biochim Biophys Acta 65: 373-375, 1962.
45. Shimazu T and Fujimoto T. Regulation of glycogen metabolism in liver by the autonomic nervous system. IV. Neural control of glycogen biosynthesis. Biochim Biophys Acta 252: 18-27, 1971.
46. Shimazu T and Fukuda A. Increased activities of glycogenolytic enzymes in liver after splanchnic-nerve stimulation. Science 150: 1607-1608, 1965.
47. Shimazu T. Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia Suppl:343-356, 1981.
48. Shimazu T, Fukuda A, and Ban T. Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content. Nature 210: 1178-1179, 1966.
49. Shimazu T and Ogasawara S. Effects of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver. Am J Physiol 228: 1787-1793, 1975.
50. Sirven A, Ravet E, Charneau P, Zennou V, Coulombel L, Guetard D, Pflumio F, and Dubart-Kupperschmitt A. Enhanced transgene expression in cord blood CD34( + )-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 3: 438-448, 2001.
51. Thaler JP and Schwartz MW. Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 151: 4109-4115, 2010.
52. Tiraby C, Tavernier G, Capel F, Mairal A, Crampes F, Rami J, Pujol C, Boutin JA, and Langin D. Resistance to high-fatdiet-induced obesity and sexual dimorphism in the metabolic responses of transgenic mice with moderate uncoupling protein 3 overexpression in glycolytic skeletal muscles. Diabetologia 50: 2190-2199, 2007.
53. Veal E and Day A. Hydrogen peroxide as a signaling molecule. Antioxid Redox Signal 15: 147-151, 2011.
54. Villeneuve C, Guilbeau-Frugier C, Sicard P, Lairez O, Ordener C, Duparc T, De Paulis D, Couderc B, Spreux-Varoquaux O, Tortosa F, Garnier A, Knauf C, Valet P, Borchi E, Nediani C, Gharib A, Ovize M, Delisle MB, Parini A, and Mialet-Perez J p53-PGC-1alpha pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid Redox Signal 18: 5-18, 2012.
55. Wahren J and Ekberg K. Splanchnic regulation of glucose production. Annu Rev Nutr 27: 329-345, 2007.
56. Yamada T and Katagiri H. Avenues of communication between the brain and tissues/organs involved in energy homeostasis. Endocr J 54: 497-505, 2007.
57. Yao F, Modgil A, Zhang Q, Pingili A, Singh N, O'Rourke ST, and Sun C. Pressor effect of apelin-13 in the rostral ventrolateral medulla: role of NAD(P)H oxidase-derived superoxide. J Pharmacol Exp Ther 336: 372-380, 2011.
58. Yu S, Zhang Y, Li MZ, Xu H, Wang Q, Song J, Lin P, Zhang L, Liu Q, Huang QX, Wang K, and Hou WK. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients. Chin Med J (Engl) 125: 3440-3444, 2012.